PSMB9 and nasopharyngeal carcinoma: As only a minor fraction of the CTLs generated from LCLs recognize the EBV proteins expressed in NPC (136, 137), protocols designed to specifically stimulate LMP1, LMP2, and EBNA1 CTLs are necessary.